Levocarnitine in Treating Fatigue in Cancer Patients
Completed · Phase 3 · Has a placebo group
Conditions studied: Fatigue, Unspecified Adult Solid Tumor, Protocol Specific
In brief
RATIONALE: Levocarnitine may help improve energy levels in cancer patients. PURPOSE: This randomized phase III trial is studying how well levocarnitine works compared to a placebo in treating fatigue in cancer patients.
Key facts
- Study ID
- NCT00091169
- Run by
- ECOG-ACRIN Cancer Research Group
- People needed
- 376
- Starts
- 2005-12-16
- Expected to finish
- 2011-05-01
- Last updated by the study team
- 2023-07-05
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Diagnosis of an invasive malignant disorder
- Moderate to severe fatigue within the past 4 weeks, defined as a score of ≥ 2 (on a scale of 0-4) on the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) question "I feel fatigued"
- Age 18 and over
- Eastern Cooperative Oncology Group (ECOG) Performance status of 0-3
- Negative pregnancy test
- Fertile patients must use effective contraception during and for 3 months after study participation
You may not qualify if…
- Brain metastases
- Hemoglobin < 9 g/dL, taken <=4 weeks prior to registration
- Severe, uncontrolled liver disease
- Evidence of severely compromised renal function including any 1 of the following:
- Renal failure
- End stage renal disease
- Ongoing renal dialysis
- Severe, uncontrolled cardiovascular disease
- Severe, uncontrolled pulmonary disease
- Pregnant or nursing
- History of seizures
- Known sensitivity to carnitine
- Delirium
- Nausea > grade 1
- Taking any form of levocarnitine (L-carnitine) supplementation or nutritional supplements containing carnitine within 2 months prior to registration
Where it is running
- Stanford Comprehensive Cancer Center - Stanford — Stanford, California, United States
- Praxair Cancer Center at Danbury Hospital — Danbury, Connecticut, United States
- Manchester Memorial Hospital — Manchester, Connecticut, United States
- Lynn Regional Cancer Center at Boca Raton Community Hospital - Main Center — Boca Raton, Florida, United States
- Baptist Cancer Institute - Jacksonville — Jacksonville, Florida, United States
- Rush-Copley Cancer Care Center — Aurora, Illinois, United States
- St. Joseph Medical Center — Bloomington, Illinois, United States
- Graham Hospital — Canton, Illinois, United States
- Memorial Hospital — Carthage, Illinois, United States
- Eureka Community Hospital — Eureka, Illinois, United States
- Evanston Northwestern Healthcare - Evanston Hospital — Evanston, Illinois, United States
- Galesburg Clinic, PC — Galesburg, Illinois, United States
- Galesburg Cottage Hospital — Galesburg, Illinois, United States
- Mason District Hospital — Havana, Illinois, United States
- Hopedale Medical Complex — Hopedale, Illinois, United States
- Joliet Oncology-Hematology Associates, Limited - West — Joliet, Illinois, United States
- McDonough District Hospital — Macomb, Illinois, United States
- BroMenn Regional Medical Center — Normal, Illinois, United States
- Community Cancer Center — Normal, Illinois, United States
- Community Hospital of Ottawa — Ottawa, Illinois, United States
- Oncology Hematology Associates of Central Illinois, PC - Ottawa — Ottawa, Illinois, United States
- Cancer Treatment Center at Pekin Hospital — Pekin, Illinois, United States
- Proctor Hospital — Peoria, Illinois, United States
- CCOP - Illinois Oncology Research Association — Peoria, Illinois, United States
- Veterans Affairs Medical Center - Palo Alto — Palo Alto, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.